Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis

Thymosin α1 is used in the clinic as a treatment in viral disease and acts as an anti-inflammatory. Here it was found to also correct the misfolding of mutant CTFR and potentiate its activity, thus improving outcome in a mouse model of cystic fibrosis. Cystic fibrosis (CF) is caused by mutations in...

Full description

Saved in:
Bibliographic Details
Published inNature Medicine Vol. 23; no. 5; pp. 590 - 600
Main Authors Romani, Luigina, Oikonomou, Vasilis, Moretti, Silvia, Iannitti, Rossana G, D'Adamo, Maria Cristina, Villella, Valeria R, Pariano, Marilena, Sforna, Luigi, Borghi, Monica, Bellet, Marina M, Fallarino, Francesca, Pallotta, Maria Teresa, Servillo, Giuseppe, Ferrari, Eleonora, Puccetti, Paolo, Kroemer, Guido, Pessia, Mauro, Maiuri, Luigi, Goldstein, Allan L, Garaci, Enrico
Format Journal Article Magazine Article
LanguageEnglish
Published New York Nature Publishing Group US 01.05.2017
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…